The ability of AD to normalize Nrf2 levels can be attributed to its inherent antioxidant compounds, which scavenge the free radicals, combatting oxidative stress; hence, the system has lower need to induce the expression of Nrf2. Here, NFE2L2 is linked to Alzheimer disease.